June 14, 2021
Using chemical synthesis, Bright Peak Therapeutics can produce proteins that have never before existed. This holds great potential for cancer immunotherapy. The Basel-based spin-off has its beginnings at ETH Zurich. Jeffrey Bode’s long, bold journey began over an after-work beer in Tokyo. A biologist friend said to the then postdoc, […]